Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.

Massive SRH can occur in RAP in the course of anti-VEGF treatment, resulting in severe vision loss. A proactive dosing regimen may be more appropriate for these RAP eyes.